RA

RAPT

RAPT Therapeutics, Inc. - Common Stock

NASDAQ
Market Cap
P/E Ratio
53.39
Dividend Yield
1.39%
Volume
52W High
52W Low
Avg Volume
52W Range

Financial Statements

What does this mean?

Income statement, balance sheet, and cash flow over time

Metric
No financial data available

Institutional Ownership

What does this mean?

Top institutions holding RAPT

Institution Shares Held Value Date
Vanguard Group 150,000,000 $25,000,000,000 Oct 2025
BlackRock 140,000,000 $23,500,000,000 Oct 2025
State Street 80,000,000 $13,500,000,000 Oct 2025
Fidelity 65,000,000 $11,000,000,000 Nov 2025
Geode Capital 35,000,000 $5,900,000,000 Nov 2025

Top ETFs holding RAPT

ETF Weight Shares
QQQ 8.50% 25,139,603
VGT 6.20% 30,446,285
SPY 4.50% 43,363,611
IVV 4.20% 43,420,941
VOO 3.80% 27,490,024

Frequently Asked Questions

Common questions about RAPT

RAPT Therapeutics, Inc. - Common Stock (RAPT) is a publicly traded company listed on NASDAQ. RAPT Therapeutics, Inc. - Common Stock (RAPT) is included in the Stock Monitor database for research and watchlists.

The current stock price of RAPT is $150.39, with a change of +1.39% in the latest session. Stock prices are updated during market hours and may be delayed.

Yes, RAPT pays dividends with a current dividend yield of 1.39%. Dividend payments are typically made quarterly, though the exact schedule varies. Check the dividend calendar for upcoming ex-dividend dates.

The P/E (Price-to-Earnings) ratio of RAPT is 53.39. This relatively high P/E may indicate growth expectations or that the stock is trading at a premium. The P/E ratio compares the stock price to earnings per share and is commonly used for valuation.

RAPT has a market capitalization of $740.00 billion, making it a mega-cap company. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.

The 52-week trading range for RAPT is $118.66 (low) to $186.33 (high). This range represents the lowest and highest prices the stock has traded at over the past year.

Trade

Buy/Sell via broker links (affiliate).

Trading 212
Open Broker
Links may be affiliate links. Trading involves risk.

Paper Trade

Save a buy/sell to your portfolio tracker (not a real trade).

Sign in to save trades to your portfolio tracker.

Paper Orders

Limit/stop reminders, with optional bracket (take profit + stop loss).

Sign in to place paper orders.

Price Alerts

Notify when RAPT crosses your target.

Sign in to create alerts and sync them across devices.

About

RAPT Therapeutics, Inc. - Common Stock (RAPT) is included in the Stock Monitor database for research and watchlists.

CEO
N/A
Employees
165,539
IPO Date
Jan 1, 2000

Analyst Ratings

What does this mean?
Goldman Sachs
Nov 28, 2025
Buy
Morgan Stanley
Nov 11, 2025
Buy
JPMorgan
Oct 25, 2025
Hold
Bernstein
Oct 8, 2025
Hold
Piper Sandler
Sep 21, 2025
Overweight
Price Target
$150.39